NCT01145222View on ClinicalTrials.gov

Multiple Dose Safety and Efficacy Study Evaluating CNS 7056 Versus Midazolam in Patients Undergoing Colonoscopy

PHASE2CompletedINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

October 31, 2010

Conditions
Sedation
Interventions
DRUG

A. CNS 7056

Initial low dose plus supplemental doses as necessary.

DRUG

B. CNS 7056

Initial intermediate dose plus supplemental doses as necessary.

DRUG

C. CNS 7056

Initial high dose plus supplemental doses as necessary.

DRUG

D. Midazolam

Initial standardized dose plus supplemental doses as necessary.

Trial Locations (9)

11794

Stony Brook University Medical Center, Stony Brook

22911

Charlottesville Medical Research, Charlottesville

27612

Wake Research Associates, Raleigh

33143

Miami Research Associates, South Miami

35660

Helen Keller Hospital, Sheffield

74104

Options Health Research, Tulsa

85050

HOPE Research Institute, Phoenix

92801

ACRI Phase I LLC, Anaheim

Advanced Clinical Research Associates, Anaheim

Sponsors
All Listed Sponsors
collaborator

Premier Research Group plc

UNKNOWN

lead

Paion UK Ltd.

INDUSTRY